Acquisition

Dannex Limited
August 29, 2016

~~Dannex Limited is the majority shareholder in both Starwin Products (71.33%) and Ayrton Drug (53.47%) Dannex intends to merge the three companies into one formidable company, both operationally and legally. The purpose of the merger is to create synergies and scale to be able to compete effectively and profitably in Ghana and West Africa. The best of the three companies would be put together to produce high quality and value for money medicines that would meet customer and consumer needs.

Dannex acquires majority stake in Starwin

Dannex Limited
December 18, 2014

~~The acquisition which was made through a rights issue makes Dannex the biggest shareholder of the company with 71.33 percent shares translating to 185,317,279 shares. 333,359,264 ordinary shares of no par value at GHS 0.03 per share in a ratio of 4.49 new shares for every one existing share held by qualifying shareholders of Starwin were offered. The offer raised a total of GHS 5,567,099.16 representing 55.67% of the intended GH 10,000,777.92. Prior to becoming the majority shareholder of Starwin, Dannex owned 2.69 percent shares in the company. In its latest acquisition Dannex acquired 6...more

Dannex donates 25,000 pieces of ORS to Ebola-stricken countries

Dannex Limited
October 10, 2014

~~Dannex Limited has presented 25,000 pieces of ORS drugs worth $25,000 to the Liberian Embassy in Ghana to aid in fight against the deadly Ebola Virus.
The move forms part of efforts to whip-up corporate support in West Africa for Ebola-stricken countries.
Inspired by how ORS is reported to have saved an Ebola patient in Nigeria, the company is hopeful that some 500 patients in Liberia can benefit from the drugs.
Dr. Ada Igonoh of the First Consultants Hospital in Nigeria is reported to have been cured from Ebola after she kept drinking ORS fluid.
The signs of E...more